Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L0ZP
|
||||
Former ID |
DNC006469
|
||||
Drug Name |
3-methoxy-4-(oxazol-5-yl)aniline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H10N2O2
|
||||
Canonical SMILES |
COC1=C(C=CC(=C1)N)C2=CN=CO2
|
||||
InChI |
1S/C10H10N2O2/c1-13-9-4-7(11)2-3-8(9)10-5-12-6-14-10/h2-6H,11H2,1H3
|
||||
InChIKey |
KYCMMXMEXWSPCV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Inosine-5'-monophosphate dehydrogenase 2 | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Purine nucleotides degradation | ||||
Urate biosynthesis/inosine 5'-phosphate degradation | |||||
Guanosine nucleotides de novo biosynthesis | |||||
Superpathway of purine nucleotide salvage | |||||
Purine nucleotides de novo biosynthesis | |||||
Guanosine ribonucleotides de novo biosynthesis | |||||
KEGG Pathway | Purine metabolism | ||||
Drug metabolism - other enzymes | |||||
Metabolic pathways | |||||
PANTHER Pathway | De novo purine biosynthesis | ||||
Reactome | Purine ribonucleoside monophosphate biosynthesis | ||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2006 May 1;16(9):2535-8. Epub 2006 Feb 17.Low molecular weight indole fragments as IMPDH inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.